Metabolomic approach to profile functional and metabolic changes in heart failure

Journal of Translational Medicine

Volumn 13, Issue 1, 2015, Pages

  Deidda, Martino ^a   Piras, Cristina ^b   Dessalvi, Christian Cadeddu ^a   Locci, Emanuela ^b   Barberini, Luigi ^b   Torri, Federica ^a   Ascedu, Federica ^a   Atzori, Luigi ^b   Mercuro, Giuseppe ^a  

^a UNIVERSITY HOSPITAL OF CAGLIARI   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Brain natriuretic peptide; Echocardiography; Energy metabolism; Heart failure; Metabolomics

Indexed keywords

2 HYDROXYBUTYRATE; GLYCINE; HYDROXYBUTYRIC ACID; INOSITOL; METHYLMALONIC ACID; UNCLASSIFIED DRUG; BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ENERGY METABOLISM; FEMALE; FUNCTIONAL ASSESSMENT; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HUMAN; LONGITUDINAL STUDY; MALE; METABOLOMICS; MIDDLE AGED; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MYOCARDIAL DISEASE; PROTON NUCLEAR MAGNETIC RESONANCE; SYSTOLIC DYSFUNCTION; AGED; BLOOD; METABOLISM; PATHOPHYSIOLOGY;

AGED; FEMALE; HEART FAILURE; HUMANS; MALE; METABOLOMICS; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROTON MAGNETIC RESONANCE SPECTROSCOPY;

EID: 84941275822     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-015-0661-3     Document Type: Article

References (34)

1. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119(3):e21.
2. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur Heart J. 2012;33(14):1787-847.
3. Neubauer S. The failing heart-an engine out of fuel. N Engl J Med. 2007;356(11):1140-51.
4. Vitale GD, deKemp RA, Ruddy TD, Williams K, Beanlands RS. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction. J Nucl Med. 2001;42(12):1730-6.
5. Lewandowski JR, De Paëpe G, Eddy MT, Struppe J, Maas W, Griffin RG. Proton assisted recoupling at high spinning frequencies. J Phys Chem B. 2009;113(27):9062-9.
6. Neubauer S. Cardiac magnetic resonance spectroscopy. Curr Cardiol Rep. 2003;5(1):75-82.
7. Griffin JL, Atherton H, Shockcor J, Atzori L. Metabolomics as a tool for cardiac research. Nat Rev Cardiol. 2011;8(11):630-43.
8. Mercuro G, Bassareo PP, Deidda M, Cadeddu C, Barberini L, Atzori L. Metabolomics: a new era in cardiology? J Cardiovasc Med (Hagerstown). 2011;12(11):800-5.
9. Du Z, Shen A, Huang Y, Su L, Lai W, Wang P, et al. 1H-NMR-Based metabolic analysis of human serum reveals novel markers of myocardial energy expenditure in heart failure patients. PLoS One. 2014;9(2):e88102.
10. Tenori L, Hu X, Pantaleo P, Alterini B, Castelli G, Olivotto I, et al. Metabolomic fingerprint of heart failure in humans: a nuclear magnetic resonance spectroscopy analysis. Int J Cardiol. 2013;168(4):e113-5.
11. Cheng ML, Wang CH, Shiao MS, Liu MH, Huang YY, Huang CY, et al. Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics. J Am Coll Cardiol. 2015;65(15):1509-20.
12. Cadeddu C, Nocco S, Deidda M, Pau F, Colonna P, Mercuro G. Altered transmural contractility in postmenopausal women affected by cardiac syndrome X. J Am Soc Echocardiogr. 2014;27(2):208-14.
13. Doenst T, Nguyen D, Abel D. Cardiac metabolism in heart failure: implications beyond ATP production. Circ Res. 2013;113(6):709-24.
14. Taegtmeyer H. Metabolism-the lost child of cardiology. J Am Coll Cardiol. 2000;36(4):1386-8.
15. Ingwall JS, Weiss RG. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res. 2004;95(2):135-45.
16. Yu CM, Lin H, Yang H, Kong SL, Zhang Q, Lee SW. Progression of systolic abnormalities in patients with "isolated" diastolic heart failure and diastolic dysfunction. Circulation. 2002;105(10):1195-201.
17. Hung CL, Verma A, Uno H, Shin SH, Bourgoun M, Hassanein AH, et al. Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarction. J Am Coll Cardiol. 2010;56(22):1812-22.
18. Marwick TH. Should we be evaluating the ventricle or the myocardium? Advances in tissue characterization. J Am Soc Echocardiogr. 2004;17(2):168-72.
19. Sykut-Cegielska J, Gradowska W, Mercimek-Mahmutoglu S, Stöckler-Ipsiroglu S. Biochemical and clinical characteristics of creatine deficiency syndromes. Acta Biochim Pol. 2004;51(4):875-82.
20. Cullen ME, Yuen AH, Felkin LE, Smolenski RT, Hall JL, Grindle S, et al. Myocardial expression of the arginine: glycine amidinotransferase gene is elevated in heart failure and normalized after recovery: potential implications for local creatine synthesis. Circulation. 2006;114(1 Suppl):I16-20.
21. Ruiz-Meana M, Pina P, Garcia-Dorado D, Rodríguez-Sinovas A, Barba I, Miró-Casas E, et al. Glycine protects cardiomyocytes against lethal reoxygenation injury by inhibiting mitochondrial permeability transition. J Physiol. 2004;558(Pt 3):873-82.
22. Ost M, Keipert S, van Schothorst EM, Donner V, van der Stelt I, Kipp AP, et al. Muscle mitohormesis promotes cellular survival via serine/glycine pathway flux. FASEB J 2015;29(4):1314-28. doi: 10.1096/fj.14-261503 .
23. Holub BJ. Metabolism and function of myo-inositol and inositol phospholipids. Annu Rev Nutr. 1986;6(1):563-97.
24. Kohl C, Schmitz W, Scholz H, Scholz J. Evidence for the existence of inositol tetrakisphosphate in mammalian heart. Effect of alpha 1-adrenoceptor stimulation. Circ Res. 1990;66(2):580-3.
25. Kawaguchi H, Sano H, Iizuka K, Okada H, Kudo T, Kageyama K, et al. Phosphatidylinositol metabolism in hypertrophic rat heart. Circ Res. 1993;72(5):966-72.
26. Santulli G, Xie W, Reiken SR, Marks AR. Mitochondrial calcium overload is a key determinant in heart failure. Proc Natl Acad Sci USA. 2015;112(36):11389-94. doi: 10.1073/pnas.1513047112 .
27. Go LO, Moschella MC, Watras J, Handa KK, Fyfe BS, Marks AR. Differential regulation of two types of intracellular calcium release channels during end-stage heart failure. J Clin Invest. 1995;95(2):888-94.
28. Gutstein DE, Marks AR. Role of inositol 1,4,5-trisphosphate receptors in regulating apoptotic signaling and heart failure. Heart Vessels. 1997;Suppl 12:53-7.
29. Santulli G, Marks AR. Essential roles of intracellular calcium release channels in muscle, brain, metabolism, and aging. Curr Mol Pharmacol. 2015. (Epub ahead of print).
30. Turer AT, Stevens RD, Bain JR, Muehlbauer MJ, van der Westhuizen J, Mathew JP, et al. Metabolomic profiling reveals distinct patterns of myocardial substrate use in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia/reperfusion. Circulation. 2009;119(13):1736-46.
31. Funada J, Betts TR, Hodson L, Humphreys SM, Timperley J, Frayn KN, Karpe F. Substrate utilization by the failing human heart by direct quantification using arterio-venous blood sampling. PLoS One. 2009;4(10):e7533.
32. Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, et al. The human serum metabolome. PLoS One. 2011;6(2):e16957.
33. Russell RR, Taegtmeyer H. Changes in citric acid cycle flux and anaplerosis antedate the functional decline in isolated rat hearts utilizing acetoacetate. J Clin Invest. 1991;87(2):384-90.
34. Russell RR, Taegtmeyer H. Pyruvate carboxylation prevents the decline in contractile function of rat hearts oxidizing acetoacetate. Am J Physiol-Heart Circ Physiol. 1991;261(6):H1756-62.